Galmarini CM, Zamora R, Gomez Del Campo P, Del Castillo-Izquierdo J, et al. PROCC: a predictive score to identify KRAS wild type metastatic colorectal cancer patients who are likely to obtain survival benefit from panitumumab treatment. Br J Cancer 2025 Aug 20. doi: 10.1038/s41416-025-03157.
PMID: 40835747